Pfizer CEO says drugmakers are ready to work with Trump on direct sales programnews2025-08-05T15:20:05+00:00August 5th, 2025|Endpoints News|
Madrigal’s MASH drug handily tops forecasts as execs discuss GLP-1 combosnews2025-08-05T15:07:44+00:00August 5th, 2025|Endpoints News|
Trump warns pharma tariffs are coming ‘in the next week or so’ news2025-08-05T14:55:34+00:00August 5th, 2025|Endpoints News|
Shattuck Labs aims to raise $103M; Beijing biotech gets $55M in Series Dnews2025-08-05T14:35:52+00:00August 5th, 2025|Endpoints News|
Pfizer says some tariffs and MFN impact factored in guidancenews2025-08-05T11:33:21+00:00August 5th, 2025|Endpoints News|
Amgen, Lilly can continue fight over alleged improper drug discounts, judge rulesnews2025-08-05T10:31:13+00:00August 5th, 2025|Endpoints News|
HMNC Brain Health plans Phase 3 for ex-Sanofi depression drug despite mid-stage missnews2025-08-05T10:00:55+00:00August 5th, 2025|Endpoints News|
Vertex’s top scientist Altshuler to retire, next-generation pain drug failsnews2025-08-05T00:57:40+00:00August 5th, 2025|Endpoints News|
Altos Labs hires a new medical chief with mTOR experience, Novartis chopsnews2025-08-04T19:50:05+00:00August 4th, 2025|Endpoints News|
J&J divests from some of its incubator sitesnews2025-08-04T19:47:20+00:00August 4th, 2025|Endpoints News|
